Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats

Peptides

Volumn 29, Issue 10, 2008, Pages 1781-1788

  Li, Dai ^a,b   Peng, Jun ^a,b   Xin, Hong Ya ^b   Luo, Dan ^a   Zhang, Yi Shuai ^a   Zhou, Zhi ^a   Jiang, De Jian ^a   Deng, Han Wu ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Blood pressure; Calcitonin gene related peptide; Platelet aggregation; Rutaecarpine; Spontaneously hypertensive rats; Tissue factor

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CAPSAZEPINE; LOSARTAN; RUTAECARPINE; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HYPERTENSION; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE AGGREGATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PLATELETS; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CARDIOTONIC AGENTS; HYPERTENSION; INDOLE ALKALOIDS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; QUINAZOLINES; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; THROMBOPLASTIN; VASODILATOR AGENTS;

RATTUS;

EID: 52049112764     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.06.010     Document Type: Article

References (29)

1. Akdemir R., Ozhan H., Yazici M., Gunduz H., Duran S., Gurel C., et al. In vivo effect of losartan on platelet aggregation in patients with hypertension. Heart Vessels 19 (2004) 167-171
2. Berggreen E., and Heyeraas K.J. Effect of the sensory neuropeptide antagonists h-CGRP(8-37) and SR 140 33 on pulpal and gingival blood flow in ferrets. Arch Oral Biol 45 (2000) 537-542
3. Booth B.P., and Fung H.L. Regulation of in vivo whole blood aggregation in rats by calcitonin gene related peptide. Can J Physiol Pharmacol 76 (1998) 811-813
4. Bowers M.C., Katki K.A., Rao A., Koehler M., Patel P., Spiekerman A., et al. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension 46 (2005) 51-57
5. Brook R.D., and Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 13 (2000) 112S-122S
6. de Meirelles L.R., Mendes-Ribeiro A.C., Santoro M.M., Mendes M.A., da Silva M.N., Mann G.E., et al. Inhibitory effects of endogenous l-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension. Clin Exp Pharmacol Physiol 34 (2007) 1267-1271
7. Deng P.Y., Ye F., Cai W.J., Tan G.S., Hu C.P., Deng H.W., et al. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens 22 (2004) 1819-1829
8. Deng P.Y., and Li Y.J. Calcitonin gene-related peptide and hypertension. Peptides 26 (2005) 1676-1685
9. Griffin G. Antiplatelet therapy and anticoagulation in patients with hypertension. Am Fam Physician 71 (2005) 897-899
10. Hu C.P., Xiao L., Deng H.W., and Li Y.J. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide. Planta Med 69 (2003) 125-129
11. Jahnel R., Dreger M., Gillen C., Bender O., Kurreck J., and Hucho F. Biochemical characterization of the vanilloid receptor 1 expressed in a dorsal root ganglia derived cell line. Eur J Biochem 268 (2001) 5489-5496
12. Li J., Kaminski N.E., and Wang D.H. Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension 41 (2003) 757-762
13. Li J., Zhao H., Supowit S.C., DiPette D.J., and Wang D.H. Activation of the rennin-angiotensin system in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. J Hypertens 22 (2004) 1345-1349
14. Li Y.J., Xiao Z.S., Peng C.F., and Deng H.W. Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts. Eur J Pharmacol 311 (1996) 163-167
15. Matsumoto Y., Ueda S., Matsushita S., Ozawa T., and Yamaguchi H. Calcitonin gene-related peptide inhibits human platelet aggregation. Jpn Circ J 60 (1996) 797-804
16. Muller I., Klocke A., Alex M., Kotzsch M., Luther T., Morgenstern E., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 17 (2003) 476-478
17. Ollivier V., Parry G.C., Cobb R.R., de Prost D., and Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271 (1996) 20828-20835
18. Prieto R., Martinez-Selles M., and Fernandez-Aviles F. Essential thrombocytemia and acute coronary syndrome: clinical profile and association with other thromboembolic events. Acute Card Care (2007) 1-5
19. Qin X.P., Zeng S.Y., Li D., Chen Q.Q., Luo D., Zhang Z., et al. Calcitonin gene-related peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J Cardiovasc Pharmacol 50 (2007) 654-659
20. Sheu J.R., Hung W.C., Lee Y.M., and Yen M.H. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur J Pharmacol 318 (1996) 469-475
21. Sheu J.R., Hung W.C., Wu C.H., Lee Y.M., and Yen M.H. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments. Br J Haematol 110 (2000) 110-115
22. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
23. Sugano T., Tsuji H., Masuda H., Nishimura H., Yoshizumi M., Kawano H., et al. Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Arterioscler Thromb Vasc Biol 21 (2001) 1078-1083
24. Sumino H., Nara M., Seki K., Takahashi T., Kanda T., Ichikawa S., et al. Effect of antihypertensive therapy on blood rheology in patients with essential hypertension. J Int Med Res 33 (2005) 170-177
25. Supowit S.C., Zhao H., Hallman D.M., and DiPette D.J. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension 29 (1997) 945-950
26. Supowit S.C., Rao A., Bowers M.C., Zhao H., Fink G., Steficek B., et al. Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage. Hypertension 45 (2005) 109-114
27. Tang Y.H., Lu R., Li Y.J., Deng H.W., and Liu G.Z. Protection by capsaicin against attenuated endothelium-dependent vasorelaxation due to lysophosphatidylcholine. Naunyn Schmiedebergs Arch Pharmacol 356 (1997) 364-367
28. Wang L., and Wang D.H. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 112 (2005) 3617-3623
29. Zhou X., and Frohlich E.D. Analogy of cardiac and renal complications in essential hypertension and aged SHR or l-NAME/SHR. Med Chem 3 (2007) 61-65